Document is current
Any future updates will be listed below
-
Authors
Marino, Emerson Cestari
Negretto, Leandra Anália Freitas
Ribeiro, Rogério Silicani
Momesso, Denise
Feitosa, Alina Coutinho Rodrigues
Toyoshima, Marcos Tadashi Kakitani
da Silva Junior, Joaquim Custódio
Vencio, Sérgio
Lauria, Marcio Weissheimer
de Sá, João Roberto
Malerbi, Domingos A.
Valente, Fernando
Leite, Silmara A. O.
Amaral, Danillo Ewerton Oliveira
Guimarães, Gabriel Magalhães Nunes
da Cunha Leal, Plínio
Lopes, Maristela Bueno
Salles, Luiz Carlos Bastos
de Araújo Azi, Liana Maria Torres
Fonseca, Amanda Gomes
Carvalho, Lorena Ibiapina M.
Coelho, Francília Faloni
Halpern, Bruno
Valerio, Cynthia M.
Trujilho, Fabio R.
Brandão, Antonio Carlos Aguiar
Lyra, Ruy
Bertoluci, Marcello
- License Information
-
More Information
Article History
Received: 21 August 2025
Accepted: 9 December 2025
First Online: 27 February 2026
Declarations
:
: Not applicable.
: Not applicable.
: ECM is a Speaker for Bayer, PTC Therapeutics and Mantecorp Farmasa laboratories. LAFN is a Speaker for the laboratories: Novo Nordisk, EMS JCSJ is a Speaker for Novo Nordisk, Eli Lilly, AstraZeneca laboratories MWL is a Speaker for Novo Nordisk, Eli Lilly, Abbott, AstraZeneca laboratories FV is a Speaker for Novo Nordisk, Boehringer Ingelheim, Eli Lilly, Abbott, AstraZeneca, Servier, EMS, GSK laboratories MB is a speaker for the following laboratories: Novo Nordisk, Lilly, Boehringer, Bayer, Aché, AstraZeneca RL has board participation and/or is a speaker for the following Labs: Lilly, Boheringer, Novonordisk, Mantecorp, Biolab, Ache, MSD, Eurofarma, Astrazeneca.
